InvestorsHub Logo

biopharm

12/18/14 1:26 PM

#200191 RE: corporalagarn #200190

I'm absolutely shocked people are taking King at his word.



King and company accomplished something no small biotech has ever done before. Phase III "Sunrise" FDA approvall with 2 peeks all based on combination data that shows the strength of PS Targeting is much stronger than previously though, combined with FDA awarded Fast Track and $63 Million on the books...

Peregrines checkmate is the quietest you'll ever hear of and Millions of more dollars rolling Bavis way is what I believe

Checkmate mate : )